Robert B. Ford - 28 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Mar 2022, 18:40:48 UTC
Prior SEC filing
23 Feb 2022
Next SEC filing
01 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Robert B. Ford filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2022.

Key facts

  • This page summarizes Robert B. Ford's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2022, 18:40.

Change

  • Previous filing in this sequence was filed on 23 Feb 2022.
  • Current net transaction value: -$3,253,535.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value
$3,253,535
Shares
-26,579
Change %
-13%
Price
$122.41
Shares after
175,485
Date
28 Feb 2022
Ownership
Direct
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
163,989
Date
28 Feb 2022
Ownership
Ford Family Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .